Showing results (381-390 of 1,537) with videos related to
Sort By:
Pageof 154
The Journal of Infectious Diseases|October 1, 1978
Diagnosis and etiology of nongonococcal urethritisS L Swartz, S J Kraus, K L Herrmann, et al.Journal of Clinical Microbiology|September 1, 1986
Volume of blood submitted for culture from neonatesP R Neal, M B Kleiman, J K Reynolds, et al.Arzneimittel-Forschung|February 1, 1990
Studies on antifungal agents. Novel cis-5-alkyl (or alkenyl)-3-phenyl-3-(1H-azol-1-ylmethyl)-2-methyl-isoxazolidine derivativesG A Bennett, P A Swift, G B Mullen, et al.Arzneimittel-Forschung|January 1, 1990
Studies on antifungal agents. In vitro activity of novel cis-5-alkoxy (or acyloxy)alkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine derivativesD M Maryniak, G B Mullen, S D Allen, et al.Journal of Chemotherapy (Florence, Italy)|October 1, 1993
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centersH S Sader, R N Jones, S D Allen, et al.Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centersR N Jones, M A Pfaller, S D Allen, et al.The Journal of Antimicrobial Chemotherapy|February 1, 1996
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limitsA L Barry, P C Fuchs, S D Allen, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1995
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methodsP C Fuchs, A L Barry, F C Tenover, et al.Journal of Medicinal Chemistry|October 1, 1988
Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivativesG B Mullen, T R DeCory, J T Mitchell, et al.Journal of Clinical Microbiology|January 1, 1995
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628A L Barry, P C Fuchs, S D Allen, et al.Pageof 154